ABSTRACT
Introduction Mechanism-of-action studies on Eye Movement Desensitization and Reprocessing have so far focused mainly on the presumed active component of bilateral stimulation (BLS). In this pilot study, a further potential working mechanism was examined for the first time, involving stimulation-induced changes in emotional valence.
Methods Twenty-five patients with posttraumatic stress disorder and 25 healthy controls between 19 and 64 years of age underwent a simulated intervention based on components of Eye Movement Desensitization and Reprocessing (EMDR). Each participant was presented with 18 individual script pairs, simulating different valence shifts (valence switch into neutral, valence switch into positive, no valence shift), whereas BLS vs. no BLS were applied. During the intervention, subjective and physiological emotional responses were measured.
Results When valence shifted to positive or neutral, a significant change in treatment-relevant subjective and physiological effect measures was found compared to scripts without a valence shift. For stimulation type, no subjective, but significant physiological effects were observed: The controls showed a physiological de-arousal under BLS, indicated by a decreased skin conductance level, and the patients showed an accelerated heart rate and an increased M. zygomaticus activity. Significant interaction effects were observed: Under BLS, the arousal-reducing and valence-changing effects of negative to neutral switches increased. Interestingly, these BLS effects became conscious to the participants only when valence switches were applied.
Discussion The findings provide new insights into the potential emotion-modulating physiological effects of BLS and its interplay with changes in emotional valence.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of the University Medicine Rostock gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability statement
The raw data of this article is freely available upon request.
